Analysis uncovers molecular differences in synovial sarcomas by age group, suggesting tailored treatments are needed.
This study reveals age-related molecular and tumor microenvironment differences in SS that may contribute to disparities in clinical outcomes. These findings underscore the need for further studies to validate these results and to support the development of age-tailored therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Bertolotti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: